Skip to main content
Erschienen in: Quality of Life Research 9/2012

01.11.2012

Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: a nationwide Danish study

verfasst von: Kirstine M. Robinson, Karl Bang Christensen, Bent Ottesen, Allan Krasnik

Erschienen in: Quality of Life Research | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

This study investigates the association between diagnostic delay (total delay), quality of life (QoL) and patient satisfaction, and the associations between QoL and patient satisfaction scores and survival for women diagnosed with ovarian or endometrial cancer.

Methods

A questionnaire survey was conducted among 723 women diagnosed with ovarian or endometrial cancer from 2006 to 2007; 453 women were chosen to participate in the study. Data on total delay (number of weeks between first cancer symptom and initiation of treatment) were available from 353 women.

Results

Experiencing longer total delay was associated with reduced overall QoL and appetite loss among ovarian cancer patients, while longer total delay was associated with reduced overall QoL, reduced role and social functioning, and increased fatigue, insomnia and constipation among endometrial cancer patients. Likewise, longer total delay was associated with decreased patient satisfaction for both cancer types. For survival and QoL scores, worse scores for pain were statistically significantly associated with reduced survival for women diagnosed with ovarian cancer, while reduced overall QoL, physical, role and emotional functioning as well as increased nausea and vomiting, pain, dyspnoea and appetite loss were associated with reduced survival for women diagnosed with endometrial cancer. For survival and patient satisfaction, associations were not significant when adjusted for diagnosis, age, cancer stage and radicality of operation.

Conclusions

We found that few QoL measures were associated with total delay and survival for ovarian cancer, while a number of associations were found between QoL, total delay and survival for endometrial cancer patients. This supports the hypothesis that long total delay may influence QoL and survival for some cancer patients. Reduced patient satisfaction with the diagnostic phase was also statistically significantly associated with long total delay, highlighting that total delay is an important component in patients’ evaluation of the care they receive.
Literatur
1.
Zurück zum Zitat Blumenthal, D. (1996). Part 1: Quality of care—What is it? New England Journal of Medicine, 335, 891–894.PubMedCrossRef Blumenthal, D. (1996). Part 1: Quality of care—What is it? New England Journal of Medicine, 335, 891–894.PubMedCrossRef
2.
Zurück zum Zitat Neal, R. D. (2009). Do diagnostic delays in cancer matter? Brit. J. Cancer, 101(Suppl 2), S9–S12.PubMedCrossRef Neal, R. D. (2009). Do diagnostic delays in cancer matter? Brit. J. Cancer, 101(Suppl 2), S9–S12.PubMedCrossRef
3.
Zurück zum Zitat Richards, M. A., Westcombe, A. M., Love, S. B., Littlejohns, P., & Ramirez, A. J. (1999). Influence of delay on survival in patients with breast cancer: A systematic review. Lancet, 353, 1119–1126.PubMedCrossRef Richards, M. A., Westcombe, A. M., Love, S. B., Littlejohns, P., & Ramirez, A. J. (1999). Influence of delay on survival in patients with breast cancer: A systematic review. Lancet, 353, 1119–1126.PubMedCrossRef
4.
Zurück zum Zitat Neal, R. D., Allgar, V. L., Ali, N., Leese, B., Heywood, P., Proctor, G., et al. (2007). Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. British Journal of General Practice, 57, 212–219.PubMed Neal, R. D., Allgar, V. L., Ali, N., Leese, B., Heywood, P., Proctor, G., et al. (2007). Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. British Journal of General Practice, 57, 212–219.PubMed
5.
Zurück zum Zitat Crawford, S. C., Davis, J. A., Siddiqui, N. A., de Caestecker, L., Gillis, C. R., Hole, D., et al. (2002). The waiting time paradox: Population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ, 325, 196.PubMedCrossRef Crawford, S. C., Davis, J. A., Siddiqui, N. A., de Caestecker, L., Gillis, C. R., Hole, D., et al. (2002). The waiting time paradox: Population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ, 325, 196.PubMedCrossRef
6.
Zurück zum Zitat Rupassara, K. S., Ponnusamy, S., Withanage, N., & Milewski, P. J. (2006). A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis. Colorectal Dis, 8, 423–429.PubMedCrossRef Rupassara, K. S., Ponnusamy, S., Withanage, N., & Milewski, P. J. (2006). A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis. Colorectal Dis, 8, 423–429.PubMedCrossRef
7.
Zurück zum Zitat Schwartz, C. E., & Sprangers, M. A. (2002). An introduction to quality of life assessment in oncology: The value of measuring patient-reported outcomes. American Journal of Managed Care, 8, S550–S559.PubMed Schwartz, C. E., & Sprangers, M. A. (2002). An introduction to quality of life assessment in oncology: The value of measuring patient-reported outcomes. American Journal of Managed Care, 8, S550–S559.PubMed
8.
Zurück zum Zitat Cella, D. F., & Tulsky, D. S. (1990). Measuring quality of life today: Methodological aspects. Oncology (Williston Park), 4, 29–38. Cella, D. F., & Tulsky, D. S. (1990). Measuring quality of life today: Methodological aspects. Oncology (Williston Park), 4, 29–38.
9.
Zurück zum Zitat Chow, A., Mayer, E. K., Darzi, A. W., & Athanasiou, T. (2009). Patient-reported outcome measures: The importance of patient satisfaction in surgery. Surgery, 146, 435–443.PubMedCrossRef Chow, A., Mayer, E. K., Darzi, A. W., & Athanasiou, T. (2009). Patient-reported outcome measures: The importance of patient satisfaction in surgery. Surgery, 146, 435–443.PubMedCrossRef
10.
Zurück zum Zitat Coates, A., Porzsolt, F., & Osoba, D. (1997). Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. European Journal of Cancer, 33, 1025–1030.PubMedCrossRef Coates, A., Porzsolt, F., & Osoba, D. (1997). Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. European Journal of Cancer, 33, 1025–1030.PubMedCrossRef
11.
Zurück zum Zitat Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002). Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer, 38, 1351–1357.PubMedCrossRef Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002). Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer, 38, 1351–1357.PubMedCrossRef
12.
Zurück zum Zitat Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008). The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology, 26, 1355–1363.PubMedCrossRef Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008). The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology, 26, 1355–1363.PubMedCrossRef
13.
Zurück zum Zitat Robinson, K. M., Ottesen, B., Christensen, K. B., & Krasnik, A. (2009). Diagnostic delay experienced among gynecological cancer patients: A nationwide survey in Denmark. Acta Obstetricia et Gynecologica Scandinavica, 88, 685–692.PubMedCrossRef Robinson, K. M., Ottesen, B., Christensen, K. B., & Krasnik, A. (2009). Diagnostic delay experienced among gynecological cancer patients: A nationwide survey in Denmark. Acta Obstetricia et Gynecologica Scandinavica, 88, 685–692.PubMedCrossRef
14.
Zurück zum Zitat The Danish Cancer Society. (2006) A cancer patients world. The Danish Cancer Society. (2006) A cancer patients world.
15.
Zurück zum Zitat Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef
16.
Zurück zum Zitat Benedet, J. L., Bender, H., Jones, H., I. I. I., Ngan, H. Y., & Pecorelli, S. (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. International Journal of Gynaecology & Obstetrics, 70, 209–262.CrossRef Benedet, J. L., Bender, H., Jones, H., I. I. I., Ngan, H. Y., & Pecorelli, S. (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. International Journal of Gynaecology & Obstetrics, 70, 209–262.CrossRef
17.
Zurück zum Zitat Thind, A., Hoq, L., Diamant, A., & Maly, R. C. (2010). Satisfaction with care among low-income women with breast cancer. Journal of Womens Health (Larchmt), 19, 77–86.CrossRef Thind, A., Hoq, L., Diamant, A., & Maly, R. C. (2010). Satisfaction with care among low-income women with breast cancer. Journal of Womens Health (Larchmt), 19, 77–86.CrossRef
18.
Zurück zum Zitat Montazeri, A. (2009). Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health and Quality of Life Outcomes, 7, 102.PubMedCrossRef Montazeri, A. (2009). Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health and Quality of Life Outcomes, 7, 102.PubMedCrossRef
19.
Zurück zum Zitat Greimel, E., Daghofer, F., & Petru, E. (2011). Prospective assessment of quality of life in long-term ovarian cancer survivors. International Journal of Cancer, 128, 3005–3011.CrossRef Greimel, E., Daghofer, F., & Petru, E. (2011). Prospective assessment of quality of life in long-term ovarian cancer survivors. International Journal of Cancer, 128, 3005–3011.CrossRef
20.
Zurück zum Zitat Carey, M. S., Bacon, M., Tu, D., Butler, L., Bezjak, A., & Stuart, G. C. (2008). The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecologic Oncology, 108, 100–105.PubMedCrossRef Carey, M. S., Bacon, M., Tu, D., Butler, L., Bezjak, A., & Stuart, G. C. (2008). The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecologic Oncology, 108, 100–105.PubMedCrossRef
21.
Zurück zum Zitat Gupta, D., Grutsch, J. F., & Lis, C. G. (2008). Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting. Journal of the Society for Integrative Oncology, 6, 98–104.PubMed Gupta, D., Grutsch, J. F., & Lis, C. G. (2008). Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting. Journal of the Society for Integrative Oncology, 6, 98–104.PubMed
22.
Zurück zum Zitat Bezjak, A., Tu, D., Bacon, M., Osoba, D., Zee, B., Stuart, G., et al. (2004). Quality of life in ovarian cancer patients: Comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. Journal of Clinical Oncology, 22, 4595–4603.PubMedCrossRef Bezjak, A., Tu, D., Bacon, M., Osoba, D., Zee, B., Stuart, G., et al. (2004). Quality of life in ovarian cancer patients: Comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. Journal of Clinical Oncology, 22, 4595–4603.PubMedCrossRef
23.
Zurück zum Zitat Groenvold, M., Klee, M. C., Sprangers, M. A., & Aaronson, N. K. (1997). Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. Journal of Clinical Epidemiology, 50, 441–450.PubMedCrossRef Groenvold, M., Klee, M. C., Sprangers, M. A., & Aaronson, N. K. (1997). Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. Journal of Clinical Epidemiology, 50, 441–450.PubMedCrossRef
Metadaten
Titel
Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: a nationwide Danish study
verfasst von
Kirstine M. Robinson
Karl Bang Christensen
Bent Ottesen
Allan Krasnik
Publikationsdatum
01.11.2012
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 9/2012
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-0077-3

Weitere Artikel der Ausgabe 9/2012

Quality of Life Research 9/2012 Zur Ausgabe